Session

Back to Programme Overview

Prostate biopsy: Improving safety, quality and efficacy

Poster Session 47

  • Location:
    Room Munich, North Hall (Level 1)
  • Chairs:
     S. Kruck, Tübingen (DE)
     V. Fradet, Quebec (CA)
     R.F. Van Velthoven, Brussels (BE)
  • Aims and objectives of this session

    This session will evaluate, interactively discuss and critique recent submitted evidence about prostate cancer biopsy techniques and protocols. An emphasis will be placed on innovative techniques an approaches to increase procedural safety and diagnostic accuracy, and patient experience.

  • Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes in length, followed by 2 minutes for discussion.
627
Comparison of patient experience after transperineal template prostate biopsy with prior transrectal ultrasound guided prostate biopsy

By: Bhatt N., Haroon U., Akram M., Drumm J., Flood H., Giri S.

Institutes: University Hospital Limerick, Dept. of Urology, Limerick, Ireland

628
Complications following extended transperineal template mapping MRI/TRUS fusion biopsy of the prostate – initial experience from 421 procedures

By: Gross O., Kaufmann B., Mortezavi A., Maerzendorfer O., Sulser T., Eberli D.

Institutes: University Hospital Zurich, Dept. of Urology, Zürich, Switzerland

629
Absence of learning curve impact may let MRI-TRUS fusion guided biopsy up for early diagnosis of prostate cancer

By: Lista G.1, Lughezzani G.1, Lazzeri M.1, Bini V.2, Hurle R.1, Buffi N.1, Cardone P.1, Casale P.1, Pasini L.1, Zandegiacomo Dezorzi S.1, Peschechera R.1, Bozzini G.3, Maffei D.4, Guazzoni G.4

Institutes: 1Istituto Clinico Humanitas, Irccs, Dept. of Urology, Milan, Italy, 2Università Degli Studi Di Perugia, Dept. of Medicine, Perugia, Italy, 3Humanitas Mater Domini, Dept. of Urology, Varese, Italy, 4Istituto Clinico Humanitas, Irccs, Humanitas University, Dept. of Urology, Milan, Italy

630
Prospective comparison of a 1.5T fast magnetic resonance imaging (MRI) protocol and the 3T multi-parametric MRI ESUR protocol as triage test for men with an elevated PSA

By: Vannieuwenhove S.2, Thiry S.1, Annet L.2, Butoescu V.1, Lecouvet F.2, Tombal B.1

Institutes: 1Cliniques Universitaires Saint-Luc, Dept. of Urology, Brussels, Belgium, 2Cliniques Universitaires Saint-Luc, Dept. of Radiology, Brussels, Belgium

631
Antimicrobial lubricant reduces rectal bacteria at transrectal prostate biopsy. Results from a large prospective randomized trial

By: Salomon G.2, Prues S.2, Saul J.2, Budäus L.2, Tilki D.2, Graefen M.2, Haferkamp A.1, Boehm K.1

Institutes: 1University Medical Center, Johannes Gutenberg University, Dept. of Urology and Pediatric Urology, Mainz, Germany, 2University Medical Center, Martini-Clinic, Hamburg, Germany

632
Rectal swab cultures and targeted prophylactic antimicrobial regimes do not reduce the risk of sepsis following transrectal prostate biopsy

By: Mulhem W., Hadjipavlou M., Eragat M., Kenny C., Cooke A., Hammadeh M.

Institutes: Queen Elizabeth Hospital, Woolwich, Dept. of Urology, London, United Kingdom

633
A prospective randomized trial of povidone-iodine suppository before transrectal ultrasound guided prostate biopsy

By: Lee I.J., Lee S., Lee S.E., Chung Y.S., Song B.D., Hong S.K., Lee H., Kim T.J.

Institutes: Seoul National University Bundang Hospital, Dept. of Urology, Seongnam-Si, South Korea

634
Prevalence and significance of fluoroquinolone-resistant bacteria carriage in patients undergoing trans rectal ultra-sonography prostate biopsy

By: Pourmand G.1, Hasanzadeh A.2, Pourmand M.R.2, Alizadeh A.3

Institutes: 1Tehran University of Medical Sciences, Urology Research Center, Tehran, Iran, 2Tehran University of Medical Sciences, Dept. of Pathobiology, Tehran, Iran, 3Tehran University of Medical Sciences, Dept. of Epidemiology and Biostatistics, Tehran, Iran

635
Cribriform pattern is highly predictive factor of biochemical recurrence in positive surgical margin patients

By: Ku J.Y., Lee C.H., Lee K., Kim K.H., Baek S.R., Park J.H., Lee J.Z., Park H.J., Han S.H., Jeong I.Y., Kwon M.J., Ha H.K.

Institutes: Pusan National University Hospital, Dept. of Urology, Busan, South Korea

636
Role of dynamic contrast-enhanced (DCE) sequences in mpMRI prostate cancer diagnosis evaluated by 5 radiology residents

By: Calleris G.1, Marra G.1, Oderda M.1, Giglio J.2, Misischi F.2, Cimpoesu P.2, Gentile F.2, Bergamasco L.3, Molinaro L.4, Frea B.1, Faletti R.2, Fonio P.2, Gontero P.1

Institutes: 1University of Turin, Dept. of Surgical Sciences, Urology, Turin, Italy, 2University of Turin, Dept. of Surgical Sciences, Radiology Unit, Turin, Italy, 3University of Turin, Dept. of Surgical Sciences, Turin, Italy, 4University of Turin, Dept. of Medical Sciences, Pathology Unit, Turin, Italy

637
Cost-effectiveness analysis of magnetic resonance imaging-ultrasound fusion biopsy versus systematic transrectal ultrasound-guided biopsy in diagnosing prostate cancer

By: Ingham M., Mossanen M., Wang Y., Chang S.

Institutes: Brigham and Women’s Hospital, Harvard Medical School, Dept. of Urology, Boston, United States of America

638
Diagnostic performance of multiparametric MRI in prostate cancer: Per core analysis of three prospective ultrasound/MRI fusion biopsy datasets

By: Ferriero M.1, Giacobbe A.2, Papalia R.3, Collura D.2, Altobelli E.3, Mastroianni R.3, Tuderti G.1, Minisola F.1, Misuraca L.1, Guaglianone S.1, Muto G.3, Gallucci M.1, Simone G.1

Institutes: 1Regina Elena National Cancer Institute, Dept. of Urology, Rome, Italy, 2San Giovanni Bosco Hospital, Dept. of Urology, Turin, Italy, 3Campus Bio-Medico University, Dept. of Urology, Rome, Italy

639
Withdrawn

By:

Institutes:

V42
Robotic MRI/US fusion transperineal biopsy using the iSR’obot Mona Lisa: Technique, safety and accuracy

By: Patel A.1, Servian P.1, Winkler M.1, Tiong L.C.2, Yuen J.3, Ho H.3, Chen K.3, Kruck S.4, Grummet J.5

Institutes: 1Imperial Healthcare NHS Trust, Dept. of Urology, London, United Kingdom, 2Ziocom Group, , Singapore, Singapore, 3Singapore General Hosital, Dept. of Urology, Singapore, Singapore, 4University Hospital Tübingen, Dept. of Urology, Tübingen, Germany, 5Monash University, Dept. of Urology, Melbourne, Australia